Bringing Data to Life: How Tech-Savvy Life Sciences Companies Can Better Serve the Healthcare Sector

When the U.S. mandate for the meaningful use of electronic health records (EHR) went into effect as part of the Health Information Technology for Economic and Clinical Health Act in 2009, hospitals and health systems across the country began evolving their processes and technology to comply. Nowadays, significant differences exist in technology sophistication and integration across these organizations. This fact coupled with the increased availability of data and ever-better computing power offers pharmaceutical companies an important opportunity to more effectively serve these important customers.

By going beyond traditional market segmentation to understand the technological and data analytics capacity of these target customers, pharma companies can fine-tune go-to-market decisions and create stronger, more tailored strategies and programs. This article demonstrates how an innovative segmentation model can enable tech-savvy life sciences companies to better serve their healthcare customers.

This byline originally appeared in Pharmaceutical Executive.

Brian Sattin, Director

Let Us Help Guide You

Complexity demands a trusted guide with the unique expertise and cross-sector versatility to deliver unwavering success. We work with organizations across regulated commercial and public sectors to catalyze transformation and pioneer new directions for the future.

Stay ahead of the curve with news, insights and updates from Guidehouse about issues relevant to your organization and its work.